| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |